Whole Exome Sequencing in Vaccine‐Induced Thrombotic Thrombocytopenia (VITT)
BioMed Research International · 2024
DOI: 10.1155/2024/2860547 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed Research International, 2024. Verfasst von Betti Giusti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Exome Sequencing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Firenze.
Abstract (Originalsprache)
Background
In February 2021, a few cases of unusual, severe thrombotic events associated with thrombocytopenia reported after vaccination with ChAdOx1 nCoV‐19 (Vaxzevria) or with Johnson & Johnson’s Janssen vaccine raise concern about safety. The vaccine‐induced thrombotic thrombocytopenia (VITT) has been related to the presence of platelet‐activating antibodies directed against platelet Factor 4.
Objectives
We investigated VITT subject genetic background by a high‐throughput whole exome sequencing (WES) approach in order to investigate VITT genetic predisposition.
Methods
Six consecutive patients (females of Caucasian origin with a mean age of 64 years) were referred to the Atherothrombotic Diseases Center (Department of Experimental and Clinical Medicine, Azienda Ospedaliero‐Universitaria Careggi, Florence) with a diagnosis of definite VITT underwent WES analysis. WES analysis was performed on the Illumina NextSeq500 platform.
Results
WES analysis revealed a total of 140,563 genetic variants. Due to VITT’s rare occurrence, we focused attention on rare variants. The global analysis of all high‐quality rare variants did not reveal a significant enrichment of mutated genes in biological/functional pathways common to patients analyzed. Afterwards, we focused on rare variants in genes associated with blood coagulation and fibrinolysis, platelet activation and aggregation, integrin‐mediated signaling pathway, and inflammation with particular attention to those involved in vascular damage, as well as autoimmune thrombocytopenia. According to ACMG criteria, 47/194 (24.2%) rare variants were classified as uncertain significance variants (VUS), whereas the remaining were likely benign/benign.
Conclusion
WES analysis identifies rare variants possibly favoring the prothrombotic state triggered by the exposure to the vaccine. Functional studies and/or extensions to a larger number of patients might allow a more comprehensive definition of these molecular pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental and Clinical Medicine University of Florence, Florence, Italy.
- Atherothrombotic Diseases Center Careggi University Hospital, Florence, Italy.
ORCID-Profile: Betti Giusti, Elena Sticchi, Tommaso Capezzuoli, Rebecca Orsi, Lapo Squillantini, Marco Giannini, Francesca Cesari, Anna Maria Gori, Rossella Marcucci
Förderung
- Università degli Studi di Firenze
Zitieren
APA
Giusti, B., Sticchi, E., Capezzuoli, T., Orsi, R., Squillantini, L., Giannini, M., Suraci, S., Rogolino, A. A., Cesari, F., Berteotti, M., Gori, A. M., Lotti, E., & Marcucci, R. (2024). Whole Exome Sequencing in Vaccine‐Induced Thrombotic Thrombocytopenia (VITT). BioMed Research International. https://doi.org/10.1155/2024/2860547
Vancouver
Giusti B, Sticchi E, Capezzuoli T, Orsi R, Squillantini L, Giannini M, et al. Whole Exome Sequencing in Vaccine‐Induced Thrombotic Thrombocytopenia (VITT). BioMed Research International. 2024. doi:10.1155/2024/2860547
BibTeX
@article{Giusti2024,
author = {Giusti, Betti and Sticchi, Elena and Capezzuoli, Tommaso and Orsi, Rebecca and Squillantini, Lapo and Giannini, Marco and Suraci, Samuele and Rogolino, Angela Antonietta and Cesari, Francesca and Berteotti, Martina and Gori, Anna Maria and Lotti, Elena and Marcucci, Rossella},
title = {Whole Exome Sequencing in Vaccine‐Induced Thrombotic Thrombocytopenia (VITT)},
journal = {BioMed Research International},
year = {2024},
doi = {10.1155/2024/2860547}
}
EUVIMED